previous compound ID: 98 next compound
InChIKey: ACPOUJIDANTYHO-UHFFFAOYSA-N
SMILES: C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"SD Macknight" "JW Hanrahan" "J Liao" "E Matthes" "DY Thomas" "R Robert" "J Goepp" "B Kus" "GW Carlile" "D Rotin"

chemical graph of compound 98





CID is 8515
synonyms found at PubChem are:
1,9-Pyrazoloanthrone, 129-56-6, SP600125, Pyrazolanthrone, Dibenzo[cd,g]indazol-6(2H)-one, Pyrazoleanthrone, SP 600125, Anthra[1,9-cd]pyrazol-6(2H)-one, Anthra-1,9-pyrazol-6-none, C.I. 70300, SP-600125, 2H-Dibenzo[cd,g]indazol-6-one, JNK Inhibitor II, SAPK Inhibitor II, NSC 75890, UNII-1TW30Y2766, ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE, EINECS 204-955-6, BRN 0746890, CHEMBL7064, MLS002693964, CHEBI:90695, ACPOUJIDANTYHO-UHFFFAOYSA-N, 2,6-DIHYDROANTHRA/1,9-CD/PYRAZOL-6-ONE, InSolution™ JNK Inhibitor II, 1TW30Y2766, NCGC00015958-03, 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one, SMR000015440, SR-01000075840, 1pmv, 2zmd, SAPK Inhibitor I, NSC75890, NSC-75890, 1 9-pyrazoleanthrone, Kinome_3844, Tocris-1496, AC1Q6DQN, BiomolKI_000068, timtec-bb sbb000595, Lopac-S-5567, BiomolKI2_000072, D00JXM, D02PVB, AC1L1R5Y, AC1Q6DR1, AC1Q6DR2, cid_8515, DSSTox_CID_20525, DSSTox_RID_79502, CBiol_002049, DSSTox_GSID_40525, Lopac0_000473, BMK1-G8, BSPBio_001066, ChemBiol10705 Compound 4, KBioGR_000406, KBioSS_000406, JMC517015 Compound 2, KSC516G2D, MLS002153267, MLS006011577, SCHEMBL170980, anthra[1,9-cd]pyrazol-6-one, GTPL5273, CHEMBL1725279, DTXSID2040525, SCHEMBL15583517, BCBcMAP01_000053, BDBM16018, CTK4B6321, KBio2_000406, KBio2_002974, KBio2_005542, KBio3_000771, KBio3_000772, MolPort-000-628-456, MolPort-002-914-349, MolPort-009-019-397, Bio1_000335, Bio1_000824, Bio1_001313, Bio2_000373, Bio2_000853, HMS1362F07, HMS1667K13, HMS1792F07, HMS1990F07, HMS2250C03, HMS3229I16, HMS3261O08, HMS3267P06, HMS3403F07, HMS3654P10, ALBB-024051, Anthra[1,9cd]pyrazol-6(2H)-one, BCP05457, c.i.70300, Tox21_110267, Tox21_500473, Anthra[1-9-cd]pyrazol-6(2H)-one, ANW-68872, BDBM50024294, BDBM50433916, CCG-47500, Dibenzo[cd,g]indazol-6(2H)-one #, HSCI1_000136, IN2388, s1460, SBB000595, ZINC96298875, AKOS000115584, Anthrapyrazolone; 1,9-Pyrazoloanthrone, CCG-100672, CS-0196, DB01782, LP00473, MCULE-7820194475, VA10299, 2,6-dihydrodibenzo[cd,g]indazol-6-one, IDI1_002128, QTL1_000077, SMP2_000240, NCGC00015958-01, NCGC00015958-02, NCGC00015958-04, NCGC00015958-05, NCGC00015958-06, NCGC00015958-07, NCGC00015958-08, NCGC00025186-01, NCGC00025186-02, NCGC00025186-03, NCGC00025186-04, NCGC00025186-05, NCGC00261158-01, WLN: T C6665 1A P IV OMNJ, AJ-50631, AN-43643, AS-14374, BAS 00719687, BC200202, CAS-129-56-6, CJ-11929, HY-12041, K914, KB-80675, LS-20607, SC-62298, SMR002530644, ST018684, TC-157617, TL8000704, EU-0100473, FT-0607068, ST24046474, EN300-02083, Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100, K00068, S 5567, SP600125, >=98% (HPLC), AB00075935-01, SP 600125 & Z-100, 129S566, SR-01000075840-1, SR-01000075840-2, SR-01000075840-4, SR-01000075840-6, SR-01000637108-1, W-108360, BRD-K01567962-001-04-0, BRD-K01567962-001-06-5, BRD-K01567962-001-08-1, BRD-K01567962-001-22-2, Z56785477, F1414-1245, SP600125, 129-56-6, 14,15-diazatetracyclo[7.6.1.0(2),.0(1)(3),(1)]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one, 14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one, 14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one